REQUEST A DEMO
Total
USD $0.00
Search more companies

Unifranco Life Sciences Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Unifranco Life Sciences Pvt Ltd Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Unifranco Life Sciences Pvt Ltd is based in India, with the head office in Hyderabad. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on February 16, 2006. From the latest financial highlights, Unifranco Life Sciences Pvt Ltd reported a net sales revenue increase of 28.85% in 2025. Over the same period, its total assets grew by 123.04%. The net profit margin of Unifranco Life Sciences Pvt Ltd decreased by 0.64% in 2025.

Legal Address
Unifranco Life Sciences Pvt Ltd D D Ap 000000 In
Hyderabad; Telangana;

Contact Details: Purchase the Unifranco Life Sciences Pvt Ltd report to view the information.

Basic Information
Registered Capital:
Purchase the Unifranco Life Sciences Pvt Ltd report to view the information.
Financial Auditors:
Purchase the Unifranco Life Sciences Pvt Ltd report to view the information.
Incorporation Date:
February 16, 2006
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Unifranco Life Sciences Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
28.85%
Total Operating Revenue
29.23%
Operating Profit
21.43%
EBITDA
21.44%
Net Profit/Loss for the Period
21.43%
Total Assets
123.04%
Total Equity
48.16%
Operating Profit Margin
-0.88%
Net Profit Margin
-0.64%
Return on Equity (ROE)
-7.27%
Debt / Equity
244.52%
Quick Ratio
1.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?